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Abstract  
A novel optically active 5,5-dioxophenothiazine-1,9 bis(thiourea) containing glucopyranosyl groups 
was synthesized and its enantiomeric recognition properties were examined toward the enantiomers 
of tetrabutylammonium salts of chiral α-hydroxy and N-protected α-amino acids using UV–vis 
spectroscopy. 
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1. Introduction 
Enantiomeric recognition as a special case of molecular recognition is a ubiquitous and vital 
phenomenon in Nature. Examples of its action include the metabolism of single enantiomeric forms 
of amino acids and sugars in biosynthetic pathways. Since the individual enantiomers of a 
biologically active compound may have different pharmacological and toxicological properties, the 
determination of the enantiomeric composition of organic compounds has great importance. 
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Carboxyl group is a particularly common functional group present in amino acids, enzymes, 
metabolic intermediates and several pharmaceutical molecules. Therefore, the synthesis and studies 
of sensor and selector molecules capable of discriminating the enantiomers of chiral carboxylic 
acids are of great interest. The enantiomers of chiral carboxylic acids can be differentiated not only 
in their neutral forms, but also as their carboxylates by enantioselective anion sensors.1–4 The most 
frequently used chiral building blocks in anion sensors are amino acids, BINOL and steroid units.1–
4 Although many monosaccharides are cheap sources of chirality and are used as asymmetric units 
in many host molecules,5–7 there are only a few enantioselective anion sensors incorporating sugar 
units.8–10 Korean researchers reported the synthesis and enantiomeric recognition studies of 
anthracene- and azophenol-based bis(thiourea) type receptors containing tetra-O-acetyl--D-
glucopyranosyl groups.8,9 They found that the latter sensor molecules showed the highest 
enantioselectivity for the enantiomers of the tetrabutylammonium salt of tert-butoxycarbonyl-
protected alanine. 
In this paper we report the synthesis of a novel 5,5-dioxophenothiazine bis(thiourea) containing 
tetra-O-acetyl--D-glucopyranosyl groups (1, Scheme 1) and the studies on its enantiomeric 
recognition ability toward the enantiomers of different optically active tetrabutylammonium 
carboxylates in acetonitrile. 
 
2. Results and discussion 
2.1. Synthesis 
The synthesis of new optically active phenothiazine bis(thiourea) 1 was carried out as outlined 
in Scheme 1. Diamine 211 was reacted with tetra-O-acetyl--D-glucopyranosyl isothiocyanate 312 in 
pyridine to give bis(thiourea) derivative 1. 
 
 
Scheme 1. Synthesis of receptor 1. 
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2.2. Anion recognition studies 
The enantiomeric recognition ability of receptor 1 was studied in acetonitrile toward the 
enantiomers of tetrabutylammonium salts of mandelic acid (Man), tert-butoxycarbonyl-protected 
phenylglycine (Boc-Phg), tert-butoxycarbonyl-protected phenylalanine (Boc-Phe) and tert-
butoxycarbonyl-protected alanine (Boc-Ala) (Fig. 1) using UV–vis spectroscopy. 
 
 
Figure 1. Optically active tetrabutylammonium carboxylates used in the enantiomeric recognition 
studies. 
 
Since basic anions often cause the deprotonation of neutral anion sensors, we recorded the 
spectrum of the deprotonated form of receptor 1 using 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
as a strong base (Fig. 2). 
 
Figure 2. Absorption spectra of 1 (20 µM) and its deprotonated form in MeCN, optical path length: 
1 cm. 
 
Upon addition of carboxylate anions only complex formation could be observed (Fig. 3) and all 
the titration series of spectra could be fitted satisfactorily assuming 1:1 complex formation (Table 
1). 
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Figure 3. Absorption series of spectra upon titration of 1 (10 µM) with (R)-Boc-Phg (0–5 equiv) in 
MeCN, optical path length: 4 cm (A), and the titration curves (0–5 equiv) with (R)- and (S)-Boc-
Phg at 300 nm (B). 
 
Table 1 
Stability constants of complexes of 1 with the enantiomers of optically active tetrabutylammonium 
carboxylates and the degrees of enantiomeric differentiation 
 log K  log K 
(R)-Man 4.92 
0.19 (S)-Man 4.73 
(R)-Boc-Phg 5.43 
0.22 
(S)-Boc-Phg 5.21 
(R)-Boc-Phe 5.88 
0.09 
(S)-Boc-Phe 5.79 
(R)-Boc-Ala 5.94 
0.04 
(S)-Boc-Ala 5.90 
 
 
The results in Table 1 show that the groups at the stereogenic centres had reasonable effect on 
enantioselectivity. Moderate enantiomeric discrimination was observed in the cases of Boc-Phg and 
Man having an aromatic moiety (phenyl group) directly attached to their stereogenic centres. If the 
phenyl group is connected to the stereogenic centre by a methylene spacer (benzyl group in Boc-
Phe), only poor enantiomeric recognition was experienced. Furthermore, there was no enantiomeric 
differentiation between the enantiomers of Boc-Ala, in which case an aliphatic group (methyl 
group) is the third substituent at the stereogenic centre. Receptor 1 formed relatively stable 
complexes with all the optically active tetrabutylammonium carboxylates studied, but the complex 
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stability constants were slightly lower in the cases when a phenyl group was directly attached to the 
stereogenic centre (Boc-Phg and Man). 
The effect of size of the protecting group on enantioselectivity was also examined in the case of 
Phg with the enantiomers of tetrabutylammonium salts of formyl-, acetyl- and pivaloyl-protected 
phenylglycine (Form-Phg, Ac-Phg and Piv-Phg, respectively, Fig. 4). 
 
Figure 4. Tetrabutylammonium salts of protected phenylglycine derivatives used in the 
enantiomeric recognition studies. 
 
With increasing bulkiness of the protecting group, the degree of enantiomeric differentation 
was increased (Table 2). Same enantioselectivity was observed in the cases of Piv-Phg and Boc-Phg 
having protecting groups of similar sizes. Bulkiness of the protecting group had no significant effect 
on stability of the complexes. 
 
Table 2 
The effect of protecting groups of Phg derivatives on enantiomeric recognition by 1 
 log K  log K 
(R)-Boc-Phg 5.43 
0.22 
(S)-Boc-Phg 5.21 
(R)-Form-Phg 5.16 
0.05 
(S)-Form-Phg 5.11 
(R)-Ac-Phg 5.45 
0.18 
(S)-Ac-Phg 5.27 
(R)-Piv-Phg 5.27 
0.22 
(S)-Piv-Phg 5.05 
 
In the case of Boc-Phg we also examined the enantiomeric recognition properties of receptor 1 
in acetonitrile-d3 using 1H NMR spectroscopy (Fig. 5). Addition of 1 equiv of (R)-Boc-Phg or (S)-
Boc-Phg caused broadening of the NH signals of receptor 1 indicating multiple hydrogen bonds in 
the complexes. The signals of the NH and the aromatic protons of Boc-Phg and one of the 
phenothiazine protons shifted upfield, while the other phenothiazine proton shifted downfield upon 
8 
complexation. The changes of the chemical shifts were larger in the case of the formation of 1–(R)-
Boc-Phg complex, which also showed the enantiomeric differentiation ability of receptor 1. 
 
Figure 5. Partial 1H NMR spectra of 1 (A), (R)-Boc-Phg (B, identical with the (S)-enantiomer), 1–
(S)-Boc-Phg complex (C) and 1–(R)-Boc-Phg complex (D) in MeCN-d3 (6 mM) at 500 MHz (a, b: 
aromatic protons of phenothiazine; c, d, e: aromatic protons of Boc-Phg; f: NH of Boc-Phg). 
 
3. Conclusion 
We studied the enantiomeric recognition properties of the newly synthesized 5,5-
dioxophenothiazine bis(thiourea) containing tetra-O-acetyl--D-glucopyranosyl groups (1) toward 
the enantiomers of tetrabutylammonium salts of optically active α-hydroxy and N-protected α-
amino acids. We have shown that the type of the third group (methyl, benzyl or phenyl) at the 
stereogenic centre had a considerable effect on the enantioselectivity. The size of the protecting 
group (formyl, acetyl, pivaloyl or tert-butoxycarbonyl) of phenylglycine also influenced the 
enantiomeric discrimination.  
 
4. Experimental 
4.1. General 
Starting materials were purchased from Sigma–Aldrich Corporation unless otherwise noted. 
Silica gel 60 F254 (Merck) plates were used for TLC. Silica gel 60 (70–230 mesh, Merck) was used 
for column chromatography. Ratios of solvents for the eluents are given in volumes (mL/mL). 
Solvents were dried and purified according to well established methods.13 Evaporations were 
carried out under reduced pressure unless otherwise stated. 
IR spectra were recorded on a Bruker Alpha-T FT-IR spectrometer. 1H (500 MHz) NMR 
spectra were obtained on a Bruker DRX-500 Avance spectrometer. 1H (300 MHz) and 13C (75 
MHz) NMR spectra were obtained on a Bruker 300 Avance spectrometer. Elemental analysis was 
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performed in the Microanalytical Laboratory of the Department of Organic Chemistry, Institute for 
Chemistry, L. Eötvös University, Budapest, Hungary. The mass spectrum was recorded on an 
Agilent-1200 Quadrupole LC/MS instrument using ESI method. Melting points were taken on a 
Boetius micro-melting point apparatus and were uncorrected.  
UV–vis spectra were taken on a Unicam UV4-100 spectrophotometer. Quartz cuvettes with 
path length of 1 cm and 4 cm were used. Enantiomers of mandelic acid and Boc-protected amino 
acids were purchased from Sigma–Aldrich Corporation. Enantiomers of formyl-protected 
phenylglycine14 and acetyl-protected phenylglycine15 were prepared in our laboratory. 
Tetrabutylammonium salts of anions were prepared by adding 1 equiv of carboxylic acid to 1 equiv 
of Bu4NOH dissolved in MeOH. After evaporating MeOH the salts were dried under reduced 
pressure over P2O5. The concentrations of the solutions of receptor 1 during the titrations were 20 
µM for Man, 10 µM for Boc-Phg, Form-Phg, Ac-Phg and Piv-Phg, 5 µM for Boc-Phe and 4 µM for 
Boc-Ala. The concentrations of the titrant solutions of chiral carboxylates were 1 mM. Stability 
constants of the complexes were determined by global nonlinear regression analysis using 
SPECFIT/32TM program. 
 
4.2. N,N'-[(3,7-di-tert-butyl-5,5-dioxo-5,10-dihydro-56-phenothiazine-1,9-
diyl)bis(azanediylcarbonothioyl)]bis(2,3,4,6-tetra-O-acetyl--D-glucopyranosylamine) (1) 
To a solution of isothiocyanate 3 (117 mg, 0.30 mmol) in pyridine (3 mL) was added a solution 
of diamine 2 (53 mg, 0.142 mmol) in pyridine (2 mL) under Ar at rt. The mixture was stirred at rt 
for 1 h. After the reaction was completed, the solution was poured into a water-ice mixture, and the 
pH was adjusted to 1 using concentrated aqueous HCl solution. The precipitate was filtered off, and 
the crude product was purified by column chromatography on silica gel using 1:20 MeOH–CH2Cl2 
as an eluent to give receptor 1 (56 mg, 34%) as pale yellow crystals. Mp: 152–155°C; Rf: 0.70 
(silica gel TLC, MeOH–CH2Cl2 1:20); = +75.3,= +79.8,= +95.4,= +224 (c 1.23, CHCl3); IR 
(KBr) max 3407, 3346, 3245, 2964, 2873, 1755, 1608, 1531, 1494, 1368, 1288, 1237, 1142, 1097, 
1037, 903 cm–1; 1H NMR (300 MHz, CDCl3)  1.28 (s, 18H), 1.82 (s, 6H), 2.00 (s, 6H), 2.03 (s, 
6H), 2.08 (s, 6H), 3.63–3.86 (m, 4H), 5.14 (t, J = 9 Hz, 2H), 5.25–5.30 (m, 4H), 5.40 (t, J = 11 Hz, 
2H), 5.56 (t, J = 9 Hz, 2H), 7.26 (br s, 1H, NH), 7.28 (br s, 2H, NH), 7.40 (d, J = 2 Hz, 2H), 7.93 (d, 
J = 2 Hz, 2H), 9.50 (br s, 2H, NH); 13C NMR (75.5 MHz, CDCl3)  19.47, 19.68, 19.84, 20.94, 
30.19, 33.89, 61.25, 68.39, 70.14, 73.80, 74.88, 82.28, 117.88, 121.17, 124.26, 129.62, 131.67, 
144.35, 168.12, 169.38, 169.49, 173.98, 184.47; MS calcd for C50H65N5O20S3: 1151.3 Found (M–
10 
H)–: 1150.3; Anal. Calcd for C50H65N5O20S3: C 52.12, H 5.69, N 6.08, S 8.35, found: C 51.92, H 
5.99, N 5.87, S 8.13. 
 
4.3. (2R)- and (2S)-[(2,2-dimethylpropanoyl)amino](phenyl)acetic acid  
To a solution of (R)- or (S)-phenylglycine (1.512 g, 10 mmol) in 4% aqueous NaOH (30 mL) 
was added pivaloyl chloride (1.568 g, 13 mmol), and the resulting mixture was stirred at rt 
overnight. The solution was acidified to pH 1 using concentrated aqueous HCl solution, and the 
precipitate was filtered off. The crude product was recrystallized from water to give the pure acids 
[799 mg, 34% for the (R)-enantiomer and 901 mg, 38% for the (S)-enantiomer] as white crystals. 
(R)-enantiomer, mp: 134–137°C;  = –155 (c 1.0, MeOH). (S)-enantiomer, mp: 135–138°C; 
 = +157 (c 1.0, MeOH); IR (KBr) max 3422, 3300–2400, 1733, 1633, 1587, 1516, 1456, 1416, 
1365, 1315, 1298, 1253, 1200, 1183, 1162, 1072, 1030, 979, 900, 862, 724, 701, 665, 636, 582, 
533, 491 cm–1; 1H NMR (500 MHz, DMSO-d6)  1.14 (s, 9H), 5.38 (d, J = 10 Hz, 1H), 7.30 (t, J = 
7 Hz, 1H), 7.35 (t, J = 7 Hz, 2H), 7.40 (d, J = 7 Hz, 2H), 7.88 (d, J = 7 Hz, 1H, NH) 12.82 (br s, 
1H); 13C NMR (75.5 MHz, DMSO-d6)  27.17, 38.00, 56.20, 127.67, 127.70, 137.58, 172.02, 
177.12. 
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